Delivery Order SPE2DB22D9244-SPE2DB25FZR99
Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $8.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,522.17 for MENVEO Vaccine VL 5S under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program. The award is firm fixed price with no set-aside designation, and the ultimate completion date is July 31, 2025. This delivery order represents one of numerous pharmaceutical product orders issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal...
- The Defense Logistics Agency awarded a $2,195.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 8, 2025, with an ultimate completion date of August 11, 2025. The delivery order covers Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, to be delivered to Conshohocken, Pennsylvania. This award carries no set-aside designation and represents a discrete delivery order issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a $1,080.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO VACCINE VL 5S medical product, with an ultimate completion date of June 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.55 to DMS Pharmaceutical Group Inc. for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was executed without a set-aside designation. The award represents a standard transactional order under DMS Pharmaceutical Group's broader pharmaceutical supply contract with DLA, fulfilling the...
- This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $4,151.64 to DMS Pharmaceutical Group Inc. for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed in Park Ridge, Illinois, the vendor's headquarters location. DMS Pharmaceutical Group Inc., a woman-owned...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $3,603.10 and a period of performance through April 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $94,236.00 to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of Menveo 1 vial (meningococcal vaccine, groups A, C, Y, and W-135) in 0.5mL dosage form. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The order will be fulfilled from DMS Pharmaceutical Group's location in Park Ridge, Illinois, and represents a component of the...